Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Uterine Neoplasms 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uncertainty × Thoracic × Clear all
NCT01929720 2017-04-05

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Completed
33 enrolled
CNSGastrointestinalGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Anxiety Disorders, Depression, Esophageal Neoplasms, Fatigue, Glioblastoma, Sleep Initiation and Maintenance Disorders, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pain, Pancreatic Neoplasms, Sleep Wake Disorders, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡